NCT01490918View on ClinicalTrials.gov

Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Acarbose

Acarbose 50mg b.i.d at first, at the 2nd week 50mg t.i.d and the 4th week, 100mg tid.

DRUG

Placebo acarbose

acarbose placebo

DRUG

placebo metformin

metformin placebo

Trial Locations (1)

137-701

MedicalExcellence, Seoul

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

The Catholic University of Korea

OTHER

NCT01490918 - Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients | Biotech Hunter | Biotech Hunter